Dual-transcriptomic analysis of human nasal transcriptome and microbiome reveals host-bacteria associations in symptomatic respiratory infection
Open Access
- 22 June 2026
- journal article
- Published by Springer Nature in BMC Genomics
- Vol. 27 (1)
Abstract
The human nasopharynx is colonized by a diverse community of commensal microbiota linked to many respiratory diseases, yet their associations with the host remain unclear. In this study, we introduced a dual-transcriptomics analysis strategy, which can characterize the host transcriptome and microbiome from nasal samples simultaneously. We applied this workflow to a local SARS-CoV-2 cohort with 76 asymptomatic infected patients, among whom 52 (68.42%) developed symptomatic infection during a 1-week follow-up period. Nasal swabs were collected from all 76 patients at enrollment and from 73 patients at one-week later follow-up. We detected a median of 8.94% reads that did not map to the human genome across all 149 samples, among which around half (median 49.68%) were successfully mapped to microbiome genome. Meta-transcriptomic analysis detected significantly higher SARS-related coronavirus loads in samples from the symptomatic group at enrollment (P = 0.004), and both groups showed decreased loads one week later (symptomatic, P = 0.001; asymptomatic, P = 0.035). Compared with benchmarking 16 S rRNA sequencing on 53 samples, our computational strategy showed high correlation of relative abundance in all top 20 genera (median Rho = 0.90, Pmax < 0.001). A total of 670 bacteria species were identified to show a relative abundance ≥ 0.01% in at least 10% samples. Differential abundance analysis identified 76 species (DASs) from six phyla with significantly decreased abundance in samples from the symptomatic group (log2(fold change or FC) < -1 and adjusted P < 0.05) compared to the asymptomatic group at enrollment. Integrating these symptom-associated DASs with host's gene expression using an expression quantitative trait bacteria (eQTB) model, we found 45 symptom-associated DASs identified at enrollment were significantly associated with one to 14 genes (adjusted P < 0.05). GSEA showed a series of symptom-associated DASs were significantly correlated with pathways related to olfactory function, keratinocyte differentiation, and DNA methylation. In summary, our dual-transcriptomic analysis strategy effectively characterized host-microbiome associations, offering insights into microbial contributions to respiratory diseases.Keywords
Funding Information
- National Center for Advancing Translational Sciences (KL2TR001856)
- Merck Investigator Studies Program (184862)
- National Institutes of Health (S10OD028483)
This publication has 63 references indexed in Scilit:
- Transcriptomic Profiles in Nasal Epithelium and Asthma Endotypes in YouthJAMA, 2025
- Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiringCancer Cell, 2023
- Specific nasopharyngeal Corynebacterium strains serve as gatekeepers against SARS-CoV-2 infectionGeroScience, 2023
- Ultrafast one‐pass FASTQ data preprocessing, quality control, and deduplication using fastpiMeta, 2023
- Bacterial communities in the nasal passage of postviral olfactory dysfunction patientsInternational Forum of Allergy & Rhinology, 2023
- Nasal Microbiome in COVID-19: A Potential Role of Corynebacterium in AnosmiaCurrent Microbiology, 2022
- Comparison of the respiratory tract microbiome in hospitalized COVID‐19 patients with different disease severityJournal of Medical Virology, 2022
- Indoor microbiome, air pollutants and asthma, rhinitis and eczema in preschool children – A repeated cross-sectional studyEnvironment International, 2022
- Human nasal microbiotaCurrent Biology, 2020
- The microbiome of the noseAnnals of Allergy, Asthma & Immunology, 2019